SGLT-2 Inhibitors: Are They a Promising Treatment Option in T2DM Patients with NAFLD?
Crossref DOI link: https://doi.org/10.14712/18059694.2018.15
Published Online: 2018-04-23
Published Print: 2017
Update policy: https://doi.org/10.14712/crossmark-policy
Patoulias, Dimitrios
Version of Record valid from 2018-04-23
Text and Data Mining valid from 2018-04-23
